Mentally challenging activities key to a healthy aging mind

  • A small study shows significant changes in brain activity among older adults engaged in learning a cognitively demanding skill.

A study involving 39 older adults has found that those randomly assigned to a “high-challenge” group showed improved cognitive performance and more efficient brain activity compared with those assigned to a low-challenge group, or a control group.

The high-challenge group spent at least 15 hours a week for 14 weeks learning progressively more difficult skills in digital photography, quilting, or a combination of both. The low-challenge group met to socialize and engage in activities related to subjects such as travel and cooking. The placebo group engaged in low-demand cognitive tasks such as listening to music, playing simple games, or watching classic movies.

The high-challenge group demonstrated increased neural efficiency in judging words, shown by lowered brain activity when word judgments were easy and increasing activity when they became hard. This is a pattern of response typical of young adults, and was not seen in them before the intervention, or among those in the other groups. To some extent, these changes were still seen a year later.

Moreover, there was a dose-dependent effect — meaning, those who spent more time engaging in the high-challenge activities showed the greatest brain changes.

So did those who were oldest, perhaps because their brains were most in need, perhaps because they were the most disengaged. Most likely, perhaps, because both of these were true.

The bottom line, though, is that, while all mental stimulation is good in terms of building cognitive reserve, actively learning, and really pushing yourself, is what you need to get to, or keep at, the top of your game.

http://www.eurekalert.org/pub_releases/2016-01/ip-mca011516.php

http://content.iospress.com/articles/restorative-neurology-and-neuroscience/rnn150533

Reference: 

Related News

Two studies help explain why kidney disease increases the risk of cardiovascular diseases such as high blood pressure and vascular calcification. The mediator seems to be a hormone called FGF23, which is sensitive to the level of phosphates in the body.

A study in which 157 healthy adult volunteers were asked to regulate their emotional reactions to unpleasant pictures, has found that those who showed greater brain activation when regulating their negative emotions also had higher blood levels of interleukin-6 (a marker for inflammation) and in

A finding that free radicals promote longevity in the roundworm challenges the theory that free radicals (oxidants) are damaging and cause aging.

A study involving 614 patients with type 2 diabetes (mean age 62) has found that longer duration of diabetes was associated with more brain volume loss, particularly in the gray matter.

Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease, but a new study shows that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women with diabetes.

A mouse study has found that introduction of oral bacteria into the bloodstream increased risk factors for atherosclerotic heart disease, including cholesterol and inflammation, suggesting that the same bacteria that cause gum disease also promotes heart disease.

A large study, involving 3,690 older adults, has found that drugs with strong anticholinergic effects cause memory and cognitive impairment when taken continuously for a mere two months.

A new study adds to growing evidence of a link between sleep problems and Alzheimer’s. The interesting thing is that this association – between sleep apnea and Alzheimer’s biomarkers — wasn’t revealed until the data was separated out according to BMI.

Family caregivers of dementia sufferers who are reluctant to use adult day care services might like to note the findings of a telephone survey. The study involved eight daily telephone interviews on consecutive days with 173 family caregivers who use an ADS on some days.

Last year, a cancer drug, Bexarotene, was touted as a potential treatment for Alzheimer’s disease. However, four independent studies have now failed to replicate the most dramatic result of the original study: a claim that the drug could clear half the amyloid plaques in a mere 72 hours.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health news